Catalyst Wire Dossier Catalyst Wire Dossier

RISPERDAL M-TAB

Risperidone · Janssen Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

20 regulatory and trial events tracked for RISPERDAL M-TAB, covering 2006-10-06 to 2025-01-22. Get the full timeline:

Most recent: FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)

See pricing